
Know Your AML Therapy: Venetoclax
Venetoclax is an oral AML therapy that is becoming more commonly used in various combinations with other AML drugs. Learn it's mechanism of action, effectiveness and side effects from Dr. Mims and come with your questions.

Katie Braswell
Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.

Alice Mims, MD
Dr. Alice Mims is the Acute Leukemia Clinical Research Director and Associate Professor in the Division of Hematology at Ohio State University Comprehensive Cancer Center. Her research focuses on studying the effectiveness of novel therapeutics for patients with AML and other myeloid neoplasms including MDS.